395 results on '"Flentje, Michael"'
Search Results
2. Trim33 masks a non-transcriptional function of E2f4 in replication fork progression
3. Assessment of dual-energy computed tomography derived virtual monoenergetic imaging for target volume delineation of brain metastases
4. Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement
5. Organerhaltende Therapie des muskelinvasiven Blasenkarzinoms: 10-Jahres-Daten der britischen BC2001-Studie
6. Radio-Chemo-Therapie
7. Salvage-Bestrahlung der Prostataloge: Mitbestrahlung der regionalen LK und Bedeutung der ADT
8. Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases
9. Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer
10. The role of beam density and arrangement in non-coplanar IMRT exemplified by the irradiation of brain tumors – Parallels to computed tomographic imaging
11. PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade radiotherapy
12. Treatment plan comparison for irradiation of multiple brain metastases with hippocampal avoidance whole brain radiotherapy and simultaneous integrated boost using the Varian Halcyon and the Elekta Synergy platforms
13. Health-related quality of life and clinical outcome after radiotherapy of patients with intracranial meningioma
14. Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma
15. Acute toxicities of patients with locally advanced rectal cancer treated with intensified chemoradiotherapy within the CAO/ARO/AIO-12 trial: comparing conventional versus VMAT planning at a single center
16. Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT)
17. Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries: A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO)
18. Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial
19. Radiotherapy in nodal oligorecurrent prostate cancer
20. Long-term results of multimodal peptide receptor radionuclide therapy and fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma
21. Evaluation of intrafraction prostate motion tracking using the Clarity Autoscan system for safety margin validation
22. Chemoradiotherapy by intensity-modulated radiation therapy with simultaneous integrated boost in locally advanced or oligometastatic non-small-cell lung cancer—a two center experience
23. Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy
24. Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
25. Ultrahypofractionation of localized prostate cancer: Statement from the DEGRO working group prostate cancer
26. Anxiety, depression and psychosocial needs are the most frequent concerns reported by patients: preliminary results of a comparative explorative analysis of two hospital-based palliative care teams in Germany and Japan
27. Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer
28. Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs
29. Comparison of sliding window and field-in-field techniques for tangential whole breast irradiation using the Halcyon and Synergy Agility systems
30. Risk factors for vertebral compression fracture after spine stereotactic body radiation therapy: Long-term results of a prospective phase 2 study
31. External validation of a prognostic score predicting overall survival for patients with brain metastases based on extracranial factors
32. The dimeric deubiquitinase USP28 integrates 53BP1 and MYC functions to limit DNA damage
33. 'Radiation Effects' in Patient Treatment
34. Impact of Radiotherapy on Malfunctions and Battery Life of Cardiac Implantable Electronic Devices in Cancer Patients
35. Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms
36. Non-rigid image registration of 4D-MRI data for improved delineation of moving tumors
37. Professor Dr. Werner Bohndorf gestorben
38. MRI-guided localization of the dominant intraprostatic lesion and dose analysis of volumetric modulated arc therapy planning for prostate cancer
39. Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy
40. Changes in penile bulb dose when using the Clarity transperineal ultrasound probe: A planning study
41. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases—A pooled analysis of the German working group “stereotactic radiotherapy”
42. Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy
43. FocAn: automated 3D analysis of DNA repair foci in image stacks acquired by confocal fluorescence microscopy
44. Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer – study protocol of a prospective, single arm, multicenter phase II trial (RACE IT)
45. Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
46. Impact of beam configuration on VMAT plan quality for Pinnacle3Auto-Planning for head and neck cases
47. Differential effects of the Akt inhibitor MK-2206 on migration and radiation sensitivity of glioblastoma cells
48. Multimodale Therapie des kleinzelligen Lungenkarzinoms: Die Rolle der Strahlentherapie
49. Hypopharyngeal and upper esophageal ulceration after cervical spine radiotherapy concurrent with crizotinib
50. Patient-reported symptoms during radiotherapy: Clinically relevant symptom burden in patients treated with palliative and curative intent
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.